NASDAQ:APYX Apyx Medical (APYX) Stock Price, News & Analysis → Your $200 account credit is about to expire (From MarketBeat) (Ad) Free APYX Stock Alerts $1.36 -0.05 (-3.55%) (As of 04:21 PM ET) Add Compare Share Share Today's Range$1.33▼$1.3950-Day Range$1.25▼$2.7152-Week Range$1.21▼$7.97Volume121,168 shsAverage Volume161,624 shsMarket Capitalization$47.11 millionP/E RatioN/ADividend YieldN/APrice Target$6.17 Stock AnalysisStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability Get Apyx Medical alerts: Email Address Apyx Medical MarketRank™ Stock AnalysisAnalyst RatingBuy3.00 Rating ScoreUpside/Downside356.4% Upside$6.17 Price TargetShort InterestBearish5.21% of Float Sold ShortDividend StrengthN/ASustainability-1.07Upright™ Environmental ScoreNews Sentiment-0.34Based on 10 Articles This WeekInsider TradingN/AProj. Earnings GrowthGrowingFrom ($0.68) to ($0.59) Per ShareSee Full Details Hide Full Details Overall MarketRank™New Rank-Based ScoringMarketRank™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.3.63 out of 5 starsMedical Sector278th out of 938 stocksSurgical & Medical Instruments Industry38th out of 97 stocks 3.5 Analyst's Opinion Consensus RatingApyx Medical has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 2 buy ratings, no hold ratings, and no sell ratings.Price Target Upside/DownsideAccording to analysts' consensus price target of $6.17, Apyx Medical has a forecasted upside of 356.4% from its current price of $1.35.Amount of Analyst CoverageApyx Medical has received no research coverage in the past 90 days. Previous Next 1.0 Short Interest Percentage of Shares Shorted5.21% of the float of Apyx Medical has been sold short.Short Interest Ratio / Days to CoverApyx Medical has a short interest ratio ("days to cover") of 10.1, which indicates bearish sentiment.Change versus previous monthShort interest in Apyx Medical has recently decreased by 1.26%, indicating that investor sentiment is improving. Previous Next 0.0 Dividend Strength Dividend YieldApyx Medical does not currently pay a dividend.Dividend GrowthApyx Medical does not have a long track record of dividend growth. Previous Next 4.2 Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreApyx Medical has received a 60.75% net impact score from Upright. The largest positive contribution comes from its "Physical diseases" impact, which is driven by its "Electrosurgical devices" product. See details.Environmental SustainabilityThe Environmental Impact score for Apyx Medical is -1.07. Previous Next 1.5 News and Social Media Coverage News SentimentApyx Medical has a news sentiment score of -0.34. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.60 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 10 news articles for Apyx Medical this week, compared to 2 articles on an average week.Search Interest8 people have searched for APYX on MarketBeat in the last 30 days. This is an increase of 300% compared to the previous 30 days.MarketBeat FollowsOnly 3 people have added Apyx Medical to their MarketBeat watchlist in the last 30 days. This is a decrease of 0% compared to the previous 30 days. Previous Next 1.7 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Apyx Medical insiders have not sold or bought any company stock.Percentage Held by Insiders13.10% of the stock of Apyx Medical is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by Institutions55.33% of the stock of Apyx Medical is held by institutions. High institutional ownership can be a signal of strong market trust in this company. Previous Next 0.6 Earnings and Valuation Earnings GrowthEarnings for Apyx Medical are expected to grow in the coming year, from ($0.68) to ($0.59) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Apyx Medical is -2.50, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Apyx Medical is -2.50, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioApyx Medical has a P/B Ratio of 1.73. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities. Previous Next See Top Rated MarketRank™ Stocks Here Ad DTIHow you can target big results without spending big money!While most folks are paying $500… $1,000… Or even MORE to trade popular stocks like Apple, Nvidia, or Microsoft… I’ve discovered a new way to tap into what could be the cheapest options on the market… I’m talking about the $0.25 Cent Trades! Click here so I can share the details of my $0.25 Cent Trades About Apyx Medical Stock (NASDAQ:APYX)Apyx Medical Corporation, an energy technology company, develops, manufactures, and sells medical devices in the cosmetic and surgical markets in the United States and internationally. It operates through two segments: Advanced Energy and Original Equipment Manufacturing (OEM). The company offers Helium Plasma Generator for delivery of RF energy and helium plasma to cut, coagulate, and ablate soft tissue during open and minimally invasive surgical procedures. Its Helium Plasma Technology products are marketed and sold as Renuvion in the cosmetic surgery market and J-Plasma in the hospital surgical market. It also develops and manufactures hand pieces for open and laparoscopic procedures; and OEM generators and related accessories. The company was formerly known as Bovie Medical Corporation and changed its name to Apyx Medical Corporation in January 2019. Apyx Medical Corporation was incorporated in 1982 and is based in Clearwater, Florida.Read More APYX Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart APYX Stock News HeadlinesMarch 26, 2024 | finance.yahoo.comDowngrade: Here's How Analysts See Apyx Medical Corporation (NASDAQ:APYX) Performing In The Near TermMarch 23, 2024 | seekingalpha.comApyx Medical Corporation (APYX) Q4 2023 Earnings Call TranscriptMarch 28, 2024 | WealthPress (Ad)$25,000 into $109,616 in two months? Today I want to show you how our research shows you could’ve grown a $25,000 account into $109,616.12 within the last TWO months. You see, former multi-million dollar hedge fund manager Roger Scott spent the better half of 2023 developing what might be the most advanced trading tool that exists… It’s a revolutionary software system that tracks the moves of institutional investors…. in real time…March 23, 2024 | finance.yahoo.comApyx Medical Corporation (NASDAQ:APYX) Just Reported And Analysts Have Been Cutting Their EstimatesMarch 22, 2024 | markets.businessinsider.comAnalysts Offer Insights on Healthcare Companies: Apyx Medical (APYX) and OKYO Pharma Limited Sponsored ADR (OKYO)March 22, 2024 | finance.yahoo.comApyx Medical Corporation (NASDAQ:APYX) Q4 2023 Earnings Call TranscriptMarch 22, 2024 | finance.yahoo.comFurther weakness as Apyx Medical (NASDAQ:APYX) drops 22% this week, taking three-year losses to 87%March 22, 2024 | markets.businessinsider.comApyx Medical (APYX) Receives a Hold from JMP SecuritiesMarch 28, 2024 | DTI (Ad)How you can target big results without spending big money!While most folks are paying $500… $1,000… Or even MORE to trade popular stocks like Apple, Nvidia, or Microsoft… I’ve discovered a new way to tap into what could be the cheapest options on the market… I’m talking about the $0.25 Cent Trades! March 21, 2024 | finance.yahoo.comQ4 2023 Apyx Medical Corp Earnings CallMarch 21, 2024 | markets.businessinsider.comAnalysts Offer Insights on Healthcare Companies: OmniAb (OABI) and Apyx Medical (APYX)March 21, 2024 | investorplace.comAPYX Stock Earnings: Apyx Medical Misses EPS, Misses Revenue for Q4 2023March 21, 2024 | msn.comApyx Medical reports mixed Q4 results; initiates FY24 outlookMarch 21, 2024 | washingtonpost.comApyx: Q4 Earnings SnapshotMarch 21, 2024 | businesswire.comApyx Medical Corporation Reports Fourth Quarter and Full Year 2023 Financial Results; Introduces Full Year 2024 Financial OutlookMarch 16, 2024 | finance.yahoo.comAPYX Apr 2024 5.000 putMarch 4, 2024 | businesswire.comApyx Medical Corporation to Release Fourth Quarter and Fiscal Year 2023 Financial Results on March 21, 2024March 4, 2024 | businesswire.comApyx Medical Corporation to Release Fourth Quarter and Fiscal Year 2023 Financial Results on March 21, 2024February 27, 2024 | markets.businessinsider.comCraig-Hallum Gives a Buy Rating to Codexis (CDXS)February 21, 2024 | finance.yahoo.comApyx Medical Corporation Announces Renuvion to be Featured in Educational Sessions at the American Academy of Cosmetic Surgery (AACS) Scientific MeetingFebruary 21, 2024 | businesswire.comApyx Medical Corporation Announces Renuvion to be Featured in Educational Sessions at the American Academy of Cosmetic Surgery (AACS) Scientific MeetingFebruary 8, 2024 | finance.yahoo.comFavourable Signals For Apyx Medical: Numerous Insiders Acquired StockFebruary 6, 2024 | morningstar.comApyx Medical CorpJanuary 22, 2024 | seekingalpha.comApyx stock rises on publication of Renuvion safety analysisJanuary 22, 2024 | finance.yahoo.comApyx Medical Corporation Announces Peer-Reviewed Clinical Publication Evaluating the Safety of Renuvion® Following Liposuction in Multiple Areas of the BodyJanuary 15, 2024 | msn.comBaird bullish on medtech in 2024, but sees weakness in dental marketJanuary 9, 2024 | finance.yahoo.comApyx Medical Corporation (APYX) Interactive Stock Chart - Yahoo FinanceSee More Headlines Receive APYX Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Apyx Medical and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings11/11/2021Today3/28/2024Next Earnings (Estimated)5/09/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Surgical & medical instruments Sub-IndustryN/A Current SymbolNASDAQ:APYX CUSIPN/A CIK719135 Webwww.apyxmedical.com Phone(727) 384-2323Fax800-323-1640Employees252Year FoundedN/APrice Target and Rating Average Stock Price Target$6.17 High Stock Price Target$9.00 Low Stock Price Target$4.50 Potential Upside/Downside+356.4%Consensus RatingBuy Rating Score (0-4)3.00 Research Coverage2 Analysts Profitability EPS (Most Recent Fiscal Year)($0.54) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-18,710,000.00 Net Margins-35.75% Pretax Margin-40.65% Return on Equity-54.90% Return on Assets-28.41% Debt Debt-to-Equity Ratio1.23 Current Ratio5.52 Quick Ratio4.74 Sales & Book Value Annual Sales$52.35 million Price / Sales0.89 Cash FlowN/A Price / Cash FlowN/A Book Value$0.78 per share Price / Book1.73Miscellaneous Outstanding Shares34,640,000Free Float30,106,000Market Cap$46.80 million OptionableOptionable Beta1.13 (Almost) Everything You Need To Know About The EV MarketClick the link below and we'll send you MarketBeat's guide to investing in electric vehicle technologies (EV) and which EV stocks show the most promise. Get This Free Report Key ExecutivesMr. Charles D. Goodwin II (Age 57)President, CEO & Director Comp: $813.13kMr. Matthew C. Hill CPA (Age 55)CFO, Treasurer & Secretary Comp: $445.95kMr. Moshe Citronowicz (Age 71)Senior Vice President Comp: $405.47kMr. Todd Hornsby (Age 47)Executive Vice President Comp: $561.77kKey CompetitorsLucid DiagnosticsNASDAQ:LUCDModular MedicalNASDAQ:MODDiCADNASDAQ:ICADDarioHealthNASDAQ:DRIOSeaStar MedicalNASDAQ:ICUView All CompetitorsInsiders & InstitutionsGreenwood Capital Associates LLCSold 9,385 shares on 3/5/2024Ownership: 0.844%Citadel Advisors LLCSold 1,300 shares on 2/15/2024Ownership: 0.000%RTW Investments LPSold 751,231 shares on 2/14/2024Ownership: 2.962%Northern Trust CorpBought 30,764 shares on 2/13/2024Ownership: 0.282%Pura Vida Investments LLCSold 756,990 shares on 2/13/2024Ownership: 0.231%View All Insider TransactionsView All Institutional Transactions APYX Stock Analysis - Frequently Asked Questions Should I buy or sell Apyx Medical stock right now? 2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Apyx Medical in the last twelve months. There are currently 2 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" APYX shares. View APYX analyst ratings or view top-rated stocks. What is Apyx Medical's stock price target for 2024? 2 brokers have issued 12-month price objectives for Apyx Medical's stock. Their APYX share price targets range from $4.50 to $9.00. On average, they expect the company's share price to reach $6.17 in the next year. This suggests a possible upside of 356.4% from the stock's current price. View analysts price targets for APYX or view top-rated stocks among Wall Street analysts. How have APYX shares performed in 2024? Apyx Medical's stock was trading at $2.62 at the start of the year. Since then, APYX shares have decreased by 48.4% and is now trading at $1.3511. View the best growth stocks for 2024 here. When is Apyx Medical's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Thursday, May 9th 2024. View our APYX earnings forecast. How were Apyx Medical's earnings last quarter? Apyx Medical Co. (NASDAQ:APYX) announced its quarterly earnings results on Thursday, November, 11th. The company reported ($0.12) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.15) by $0.03. The company earned $11.83 million during the quarter, compared to the consensus estimate of $10.83 million. Apyx Medical had a negative trailing twelve-month return on equity of 54.90% and a negative net margin of 35.75%. During the same quarter last year, the company posted ($0.13) earnings per share. What guidance has Apyx Medical issued on next quarter's earnings? Apyx Medical updated its FY 2024 earnings guidance on Thursday, March, 21st. The company provided EPS guidance of for the period. The company issued revenue guidance of $49.7 million-$52.9 million, compared to the consensus revenue estimate of $59.8 million. What other stocks do shareholders of Apyx Medical own? Based on aggregate information from My MarketBeat watchlists, some companies that other Apyx Medical investors own include Main Street Capital (MAIN), Johnson & Johnson (JNJ), ONEOK (OKE), Occidental Petroleum (OXY), Procter & Gamble (PG), STORE Capital (STOR), Wells Fargo & Company (WFC), Boeing (BA), Bank of America (BAC) and Delta Air Lines (DAL). Who are Apyx Medical's major shareholders? Apyx Medical's stock is owned by a number of retail and institutional investors. Top institutional investors include AIGH Capital Management LLC (5.89%), RTW Investments LP (2.96%), Taylor Frigon Capital Management LLC (1.84%), Silverberg Bernstein Capital Management LLC (1.77%), Raymond James Financial Services Advisors Inc. (1.76%) and Worth Venture Partners LLC (1.50%). Insiders that own company stock include Charles D Goodwin II, Matthew C Hill and Todd Hornsby. View institutional ownership trends. How do I buy shares of Apyx Medical? Shares of APYX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NASDAQ:APYX) was last updated on 3/28/2024 by MarketBeat.com Staff From Our PartnersGrab Your Free Bitcoin Today!Crypto Swap ProfitsMake This $3 Trade the Instant the Opening Bell RingsMonument Traders AllianceTop Project Outperforms BTC in 2023…Crypto 101 MediaThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading Academy“The Stock Market’s Bull Run is Far from Over” -BarronsVertical Research AdvisoryMost important medical advance in 100 yearsThe Oxford ClubFed launches fourth dollar overhaulStansberry ResearchBuy this small stock before coming AI Tidal WaveChaikin Analytics Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Apyx Medical Co. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.